ECIG_FORMULATIONS_LIMITED - Accounts


Company Registration No. 09887693 (England and Wales)
ECIG FORMULATIONS LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020
ECIG FORMULATIONS LIMITED
COMPANY INFORMATION
Directors
S D Baxter
G H Williams
L Beesley
K Barker
Company number
09887693
Registered office
Upper Icknield Way
Tring
Hertfordshire
HP23 4JZ
Accountants
Mercer & Hole
Batchworth House
Batchworth Place
Church Street
Rickmansworth
Hertfordshire
WD3 1JE
Business address
Upper Icknield Way
Tring
Hertfordshire
HP23 4JZ
ECIG FORMULATIONS LIMITED
CONTENTS
Page
Directors' report
1
Accountants' report
2
Balance sheet
3
Notes to the financial statements
4 - 5
ECIG FORMULATIONS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JULY 2020
- 1 -

The directors present their annual report and financial statements for the year ended 31 July 2020.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

S D Baxter
G H Williams
L Beesley
K Barker

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
S D Baxter
Director
21 April 2021
ECIG FORMULATIONS LIMITED
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ECIG FORMULATIONS LIMITED FOR THE YEAR ENDED 31 JULY 2020
- 2 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of ECIG Formulations Limited for the year ended 31 July 2020 set out on pages 3 to 5 from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of ECIG Formulations Limited, as a body, in accordance with the terms of our engagement letter dated 1 October 2016. Our work has been undertaken solely to prepare for your approval the financial statements of ECIG Formulations Limited and state those matters that we have agreed to state to the Board of Directors of ECIG Formulations Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ECIG Formulations Limited and its Board of Directors as a body, for our work or for this report.

It is your duty to ensure that ECIG Formulations Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and result of ECIG Formulations Limited. You consider that ECIG Formulations Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of ECIG Formulations Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Mercer & Hole
21 April 2021
Chartered Accountants
Batchworth House
Batchworth Place
Church Street
Rickmansworth
Hertfordshire
WD3 1JE
ECIG FORMULATIONS LIMITED
BALANCE SHEET
AS AT
31 JULY 2020
31 July 2020
- 3 -
2020
2019
Notes
£
£
£
£
Current assets
Cash at bank and in hand
200
200
Net current assets
200
200
Capital and reserves
Called up share capital
4
200
200

For the financial year ended 31 July 2020 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 21 April 2021 and are signed on its behalf by:
S D Baxter
Director
Company Registration No. 09887693
ECIG FORMULATIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020
- 4 -
1
Accounting policies
Company information

ECIG Formulations Limited is a private company limited by shares incorporated in England and Wales. The registered office is Upper Icknield Way, Tring, Hertfordshire, HP23 4JZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.3
Intangible fixed assets - goodwill

lntangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

lntangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably.

1.4
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Total
-
0
-
0
ECIG FORMULATIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2020
- 5 -
3
Intangible fixed assets
Intellectual property
£
Cost
At 1 August 2019 and 31 July 2020
50,000
Amortisation and impairment
At 1 August 2019 and 31 July 2020
50,000
Carrying amount
At 31 July 2020
-
0
At 31 July 2019
-
0
4
Called up share capital
2020
2019
£
£
Ordinary share capital
Issued and fully paid
6 Ordinary "A" shares of £1 each
6
6
94 Ordinary "B" shares of £1 each
94
94
100 Ordinary shares of £1 each
100
100
200
200

All share classes rank pari passu in all respects.

2020-07-312019-08-01trueCCH SoftwareCCH Accounts Production 2021.100No description of principal activityS D BaxterG H WilliamsL BeesleyK Barker098876932019-08-012020-07-3109887693bus:Director12019-08-012020-07-3109887693bus:Director22019-08-012020-07-3109887693bus:Director32019-08-012020-07-3109887693bus:Director42019-08-012020-07-3109887693bus:RegisteredOffice2019-08-012020-07-31098876932020-07-31098876932019-07-3109887693core:ShareCapital2020-07-3109887693core:ShareCapital2019-07-3109887693core:ShareCapitalOrdinaryShares2020-07-3109887693core:ShareCapitalOrdinaryShares2019-07-3109887693core:Goodwill2019-08-012020-07-31098876932018-08-012019-07-3109887693core:NetGoodwill2019-07-3109887693core:NetGoodwill2020-07-3109887693core:NetGoodwill2019-07-3109887693bus:EntityNoLongerTradingButTradedInPast2019-08-012020-07-3109887693bus:PrivateLimitedCompanyLtd2019-08-012020-07-3109887693bus:FRS1022019-08-012020-07-3109887693bus:AuditExemptWithAccountantsReport2019-08-012020-07-3109887693bus:FullAccounts2019-08-012020-07-31xbrli:purexbrli:sharesiso4217:GBP